ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted

July 19, 1991

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

Clinical Research Program Announcement

February 13, 1981

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982